Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs Penicillin V in Pediatric Tonsillitis/Pharyngitis
NCT00315042Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Mar 2006
- Primary completion
- Aug 2006
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of telithromycin in tonsillitis and pharyngitis (2 arms), sponsored by Sanofi. Primary endpoint: Bacteriologic efficacy at posttherapy/test-of-cure (TOC) visit. Started Mar 2006; status: terminated.
02
Drugs
telithromycin
03
Conditions
tonsillitispharyngitis
Beyond the preview
Go deeper on NCT00315042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315042.